Published in Gynecol Oncol on May 20, 2011
Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics (2013) 2.27
Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med (2011) 2.10
Exosomal miRNAs: Biological Properties and Therapeutic Potential. Front Genet (2012) 1.60
Cell-free Circulating miRNA Biomarkers in Cancer. J Cancer (2012) 1.37
Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling. J Biol Chem (2013) 1.22
MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer. Onco Targets Ther (2014) 1.22
Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment. Oncoimmunology (2015) 1.05
Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients. Oncotarget (2014) 1.05
Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium. J Extracell Vesicles (2015) 1.02
Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis. J Extracell Vesicles (2015) 1.02
Extracellular vesicle transfer of cancer pathogenic components. Cancer Sci (2016) 1.01
Circulating RNAs as new biomarkers for detecting pancreatic cancer. World J Gastroenterol (2015) 1.01
Microvesicles/exosomes as potential novel biomarkers of metabolic diseases. Diabetes Metab Syndr Obes (2012) 1.01
Sensitive PCR-based quantitation of cell-free circulating microRNAs. Methods (2012) 0.98
Extracellular vesicle isolation and characterization: toward clinical application. J Clin Invest (2016) 0.95
EpCAM proteolysis: new fragments with distinct functions? Biosci Rep (2013) 0.91
Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer. Cancer Biol Med (2013) 0.90
Pancreatic cancer diagnosis by free and exosomal miRNA. World J Gastrointest Pathophysiol (2013) 0.89
Linear Discriminant Functions in Connection with the micro-RNA Diagnosis of Colon Cancer. Cancer Inform (2011) 0.87
Interactions between cancer cells and normal cells via miRNAs in extracellular vesicles. Cell Mol Life Sci (2015) 0.87
Roles of microRNA-140 in stem cell-associated early stage breast cancer. World J Stem Cells (2014) 0.87
Enhanced size-dependent trapping of particles using microvortices. Microfluid Nanofluidics (2013) 0.86
Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal-maternal interface. Histochem Cell Biol (2016) 0.85
Exosomal miRNAs as cancer biomarkers and therapeutic targets. J Extracell Vesicles (2016) 0.83
Soluble EpCAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitro. BMC Cancer (2015) 0.79
Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions. Oncotarget (2016) 0.79
New insights in the composition of extracellular vesicles from pancreatic cancer cells: implications for biomarkers and functions. Proteome Sci (2014) 0.78
sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients. J Exp Clin Cancer Res (2015) 0.78
From pathogenesis to clinical application: insights into exosomes as transfer vectors in cancer. J Exp Clin Cancer Res (2016) 0.77
The Role of Isolation Methods on a Nanoscale Surface Structure and its Effect on the Size of Exosomes. J Circ Biomark (2016) 0.77
Plant derived edible nanoparticles as a new therapeutic approach against diseases. Tissue Barriers (2016) 0.76
Texosome-based drug delivery system for cancer therapy: from past to present. Cancer Biol Med (2015) 0.76
Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic Phenotype. Biomed Res Int (2015) 0.76
Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers. Expert Rev Mol Diagn (2016) 0.76
Impaired activation of ALS monocytes by exosomes. Immunol Cell Biol (2016) 0.76
Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations. J Extracell Vesicles (2016) 0.76
Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification. PLoS One (2017) 0.75
Differential Protein Expression Marks the Transition From Infection With Opisthorchis viverrini to Cholangiocarcinoma. Mol Cell Proteomics (2017) 0.75
Exosomes in Cancer Diagnostics. Cancers (Basel) (2017) 0.75
Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic Applications. Cancers (Basel) (2017) 0.75
The potential of exosomes in diagnosis and treatment of inborn errors of metabolism. J Inherit Metab Dis (2014) 0.75
Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes. Nat Biomed Eng (2017) 0.75
Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics (2002) 20.59
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol (2013) 4.11
Cholesterol, lipid rafts, and disease. J Clin Invest (2002) 4.05
Exosomes: from biogenesis and secretion to biological function. Immunol Lett (2006) 3.82
Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol (2012) 3.18
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell (2013) 3.08
Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer (2011) 3.02
Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer (2010) 2.95
Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. J Am Coll Cardiol (2006) 2.73
Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res (2007) 2.62
The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res (2007) 2.54
Marked gene transcript level alterations occur early during radical prostatectomy. Eur Urol (2007) 2.41
L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol (2005) 2.39
Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization. Anal Biochem (2004) 2.28
Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity. BMC Med Genomics (2011) 2.24
Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell (2008) 2.21
CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res (2003) 2.15
Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med (2011) 2.10
Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J Biol Chem (2005) 2.03
A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res (2007) 2.03
arrayMagic: two-colour cDNA microarray quality control and preprocessing. Bioinformatics (2004) 2.02
A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem J (2006) 1.92
Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett (2009) 1.84
Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer (2011) 1.76
ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy. Clin Cancer Res (2011) 1.75
Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung Cancer (2008) 1.71
Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol Oncol (2007) 1.68
L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet (2003) 1.67
Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial. Ann Intern Med (2007) 1.67
The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. J Immunol (2009) 1.65
Preeclampsia: increased expression of soluble ADAM 12. J Mol Med (Berl) (2005) 1.59
ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J (2002) 1.58
Molecular cancer phenotype in normal prostate tissue. Eur Urol (2008) 1.58
CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients. Int J Cancer (2010) 1.56
Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin Cancer Res (2005) 1.54
Cellular uptake of fatty acids driven by the ER-localized acyl-CoA synthetase FATP4. J Cell Sci (2006) 1.52
L1CAM: a major driver for tumor cell invasion and motility. Cell Adh Migr (2012) 1.52
FAT/CD36-mediated long-chain fatty acid uptake in adipocytes requires plasma membrane rafts. Mol Biol Cell (2004) 1.51
Identification of aberrant chromosomal regions from gene expression microarray studies applied to human breast cancer. Bioinformatics (2007) 1.50
Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res (2005) 1.50
L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Mol Cell Biol (2005) 1.47
The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7. Exp Cell Res (2005) 1.47
Estimating large-scale signaling networks through nested effect models with intervention effects from microarray data. Bioinformatics (2008) 1.46
Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer. Breast Cancer Res Treat (2008) 1.42
Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neurosci Lett (2007) 1.41
ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction. Clin Cancer Res (2010) 1.41
Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA. Cancer Res (2008) 1.41
L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation. J Natl Cancer Inst (2013) 1.40
Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res (2006) 1.35
CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. J Cell Sci (2006) 1.30
Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis. Inflamm Bowel Dis (2009) 1.30
Anti-inflammatory effects of phosphatidylcholine. J Biol Chem (2007) 1.29
Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion. J Cell Biochem (2008) 1.27
Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol Ther (2010) 1.26
TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling. BMC Cancer (2011) 1.26
Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential. PLoS One (2012) 1.25
Systematic analysis of T7 RNA polymerase based in vitro linear RNA amplification for use in microarray experiments. BMC Genomics (2004) 1.25
L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecol Oncol (2006) 1.25
Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model. Cancer Res (2007) 1.24
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer. J Mol Med (Berl) (2012) 1.23
Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling. J Biol Chem (2013) 1.22
Mnd1 is required for meiotic interhomolog repair. Curr Biol (2004) 1.22
Combinatorial RNAi for quantitative protein network analysis. Proc Natl Acad Sci U S A (2007) 1.21
Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation. Cancer Discov (2012) 1.21
Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer. Cancer Res (2009) 1.20
L1CAM malfunction in the nervous system and human carcinomas. Cell Mol Life Sci (2010) 1.20
Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas. J Pathol (2010) 1.20
EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation. Carcinogenesis (2012) 1.20
Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors. Clin Cancer Res (2005) 1.19
Brain development in mice lacking L1-L1 homophilic adhesion. J Cell Biol (2004) 1.19
Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma. Oncotarget (2014) 1.18
Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors. J Clin Invest (2004) 1.16
The N-terminal region of acyl-CoA synthetase 3 is essential for both the localization on lipid droplets and the function in fatty acid uptake. J Lipid Res (2012) 1.16
EZH2 depletion blocks the proliferation of colon cancer cells. PLoS One (2011) 1.15
Integration of pathway knowledge into a reweighted recursive feature elimination approach for risk stratification of cancer patients. Bioinformatics (2010) 1.15
Dietary polyphenol quercetin targets pancreatic cancer stem cells. Int J Oncol (2010) 1.14
Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis. Lab Invest (2010) 1.14
Long-chain fatty acid uptake into adipocytes depends on lipid raft function. Biochemistry (2004) 1.14
Acyl-CoA synthetases: fatty acid uptake and metabolic channeling. Mol Cell Biochem (2008) 1.13
ADAM10 is upregulated in melanoma metastasis compared with primary melanoma. J Invest Dermatol (2009) 1.11